Mai Pu Medical: Absorbable regenerative oxidized cellulose hemostatic particles enter clinical trials.

Imp Medical announced that the company's research and development project "absorbable regenerative oxidized cellulose hemostatic granules" has officially entered the clinical trial stage. The product is classified as a Class III medical device and can be used as an auxiliary hemostatic product in surgical procedures to control bleeding from capillaries, veins, and small arteries. After the completion of the clinical trial, the company plans to carry out the registration application and industrialization for market sales. The conduct of this clinical trial will enrich the company's product line in the field of surgery, but the specific impact on the company's future performance cannot be predicted at this time.